https://join.freeconferencecall.com/pharmacy8

DayDateAM/PMSessionAgendaChairScribe

Co-Chair
Availability

Room
SundayFebruary 2, 2020AMQ1Not Meeting



AMQ2Not Meeting



AM

Q3

Not Meeting



AMQ4Not Meeting












MondayFebruary 3, 2020AMQ1

Not Meeting





AMQ2Not Meeting



PMQ3Not Meeting



PMQ4Not Meeting












TuesdayFebruary 4, 2020AMQ1

Meeting

  • Review Agenda
  • Reps to other WGs
    • Wed Q2 - O&O - HealthcareProduct: Substance, Substance Definition, BiologicallyDerivedProduct, Supply, Medication, MedicinalProduct, MedicationKnowledge - Scott
    • Wed Q4 - Public Health - confirmed with Public Health that there are no agenda topics
    • Thurs Q3 - CDS - will cancel and all go to CDS
    • Fri Q1 - Patient Care - Care Plan report out - Scott
  • Assign Roles for Quarters
  • Approval of September 2019 WGM Minutes
  • If we have new attendees, review
    • Overview of Pharmacy material - V2, V3, FHIR
    • Overview of Template work
  • Hot Topics
  • Prep for Joint FHIR meeting
JeanMelva

Melva

Jean

Scott

E3.3
AMQ2

Meeting

MelvaScott

Melva

Scott

E3.3
AMQ3

Meeting

ScottMelva

Melva

Jean

Scott

E3.3
PMQ4

Meeting

  • Discuss Medication List with Michelle Miller
MelvaJean

Melva

Scott

Jean

E3.3









WednesdayFebruary 5, 2020AMQ1Not Meeting



AMQ2

Not Meeting - Rep to O&O





PMQ3Not Meeting



PMQ4

Not Meeting














ThursdayFebruary 6, 2020AMQ1

Meeting

  • Medication List Project
MelvaJean

Jean

Melva

? Scott

E3.5
AMQ2

Meeting

  • Medication List Project
ScottMelva

Jean

Melva

Scott

E3.5
PM

Q3

Not Meeting - CANCELLED






PMQ4

Meeting

  • VA Pharmacy Project - Jay Lyle (material to be provided)
    • Questions:
      • Do these maps make sense? Are there assumptions I’m missing? Are there better approaches?
      • Are there changes coming that might affect our approach?
      • What other stakeholders would be interested in comparing extensions? What’s the best channel for that discussion?
    • Attachments:
      • VAPharmaMaps.xlsx
        • Notes:
          • Columns A-J are VistA metadata. K-R are the proposed design description.

          • There’s a legend for the column headers.

          • The areas of most interest will be the orders in the area (B) column:

            • Inpatient Orders - pending/non-verified

            • Inpatient Orders IV/Clinic Infusions

            • Inpatient Orders Unit Dose/Clinic Medications

            • Outpatient Orders

            • Outpatient Orders - pending

            • Non-VA Medications

      • DD19_20191122_1155_JayLyle_BalancingActExposingLegacyDataInFHIR.pptx
        • I also attach a slide deck for a high-level overview of what’s going on in there, for what it’s worth, which you can read or I can present, or both.

MelvaScott

Melva

Scott

E3.5









Friday

February 7, 2020

AMQ1

Meeting - Rep to Patient Care

Project Management

  • Schedule for Conference calls
  • DMP - 2018
  • M&C - 2018
  • SWOT - 2018
  • Reaffirmation/Withdrawal of 5 year items
  • Forward Planning
  • Project Review
    • 3 year plan review
  • Action Item list review
  • Addition of another chair
MelvaMelva

Jean

Melva


E3.5
AMQ2

Joint Meeting with FHIR-I - Pharmacy Hosting

JeanMelva

Jean

Melva

Scott

E3.5
PMQ3

Not Meeting





PMQ4

Not Meeting